Can an HCSA be signed electronically?

Yes. Electronic signatures are legally enforceable under the federal ESIGN Act (15 U.S.C. ch. 96) and state UETA laws in most jurisdictions, subject to limited statutory exceptions. Confirm institutional policies and any required consent disclosures for consumer-facing or government-funded transactions.

Do I need a HIPAA BAA for eSigning?

If the platform will store or transmit protected health information, a Business Associate Agreement is required to allocate responsibilities and ensure HIPAA safeguards are in place. Verify the platform’s HIPAA compliance options before sending PHI-containing documents.

What signer authentication is sufficient?

Select authentication appropriate to risk: simple email link for low-risk approvals, SMS or SSO for moderate assurance, and multi-factor or institutional SSO for high-assurance clinical agreements involving PHI or substantial payments.

Are notarization or witnesses required?

Not usually for HCSAs, but some institutions or state rules may require notarization for specific signature authorities or amendments. Check institutional policies and state notary guidance before execution.

How do I protect PHI in shared signed documents?

Limit access, redact nonessential identifiers where possible, store executed agreements in secure repositories, and maintain a logging and retention policy consistent with HIPAA and institutional rules.

What records should be retained after study close?

Retain the executed HCSA, protocol versions, IRB approvals, consent forms, and financial records per retention policy; federal and HIPAA baselines apply, and some studies may require longer retention for sponsor or regulator reasons.

Electronic Signature
Templates
Healthcare
Healthcare Clinical Study Agreement

Healthcare Clinical Study Agreement

This template is fully customizable. Edit the text, fill out the fields, and send it for signature. Give it a try!

HEALTHCARE CLINICAL STUDY AGREEMENT

This Clinical Study Agreement ("Agreement") is entered into as of Effective Date: by and between Sponsor: and Site/Institution: .

PARTIES & STUDY IDENTIFIERS

Study Title: Protocol Number: Principal Investigator:

Sponsor Primary Contact Site Contact

RECITALS & DEFINITIONS

WHEREAS, Sponsor is conducting the research study identified above and desires to engage Site to perform clinical trial activities in accordance with the study protocol and applicable law; and WHEREAS, Site has the capability and agrees to perform study activities in accordance with the protocol, good clinical practice, and all applicable legal and regulatory requirements. For purposes of this Agreement, "Confidential Information" means all non-public clinical, proprietary, technical, financial, or business information exchanged in connection with the study, excluding information that is or becomes publicly available through no breach by a receiving party.

SCOPE OF WORK

Description of Services (Site will perform):

PROTOCOL, IRB, & SUBJECT PROTECTION

Site shall obtain and maintain written approval from its Institutional Review Board (IRB) or Ethics Committee prior to initiating any study procedures and shall obtain informed consent from each research subject in accordance with the approved informed consent form. IRB/EC Name: IRB Approval Date:

Subject Enrollment Estimate

COMPENSATION & BUDGET

Sponsor agrees to pay Site for services rendered in accordance with the Budget Attachment and the Payment Schedule below. Payment shall be full compensation for all Site obligations unless otherwise expressly agreed in writing.

Total Maximum Budget Payment Schedule Summary

Attachments Included:

Protocol Budget Informed Consent Form Investigator Brochure

CONFIDENTIALITY & DATA RIGHTS

All Confidential Information exchanged under this Agreement shall be held in strict confidence. Sponsor shall own all Study Data and all rights, title and interest in and to the data, results and analyses generated by the study, subject to Site's limited right to use de-identified subject data for internal quality assurance and teaching purposes consistent with applicable law. Site shall not disclose individually identifiable subject data without Sponsor's prior written consent and applicable subject authorization.

Data Transfer and De-Identification Procedures

SAFETY, REPORTING & INSPECTION

Site shall promptly report serious adverse events and unanticipated problems to Sponsor and the IRB in accordance with protocol and applicable law. Sponsor shall report safety information to regulatory authorities as required. Site shall permit Sponsor, or its designees, regulatory authorities, and IRB/EC reasonable access to study records for monitoring, audit and inspection, subject to protection of patient confidentiality.

Adverse Event Reporting Procedures

INSURANCE & INDEMNIFICATION

Each party shall maintain appropriate insurance coverage for its obligations under this Agreement. Sponsor shall indemnify and hold harmless Site, its employees and agents from and against liabilities arising from the design, manufacture or provision of the investigational product, except to the extent caused by Site's negligence or willful misconduct. Site shall indemnify Sponsor for liabilities arising from Site's negligent performance of study procedures.

Insurance Certificate Provided

Sponsor Provided Site Provided

TERM, TERMINATION & SURVIVAL

This Agreement shall commence on the Effective Date and remain in effect until completion of the Study or earlier termination. Either party may terminate for material breach if the other party fails to cure within the time specified in a written notice. The obligations of confidentiality, indemnification, data ownership and compensation for services performed prior to termination shall survive termination.

Termination Notice Period (days)

GOVERNING LAW & DISPUTE RESOLUTION

This Agreement shall be governed by and construed in accordance with the laws agreed by the parties below. Any dispute arising under this Agreement shall be resolved by the dispute resolution procedure set forth here: Jurisdiction / Governing Law:

NOTICES

Sponsor Notice Address Site Notice Address

MISCELLANEOUS

This Agreement constitutes the entire agreement between the parties with respect to the subject matter and supersedes all prior negotiations and agreements. Any amendment must be in writing and signed by both parties. Neither party may assign this Agreement without the other's prior written consent except that Sponsor may assign to an affiliate or successor in interest.

Record Retention Period (years)

SIGNATURES

Sponsor (Print Name):

By:

Date:

Site/Institution (Print Name):

By:

Date:

What a Healthcare Clinical Study Agreement Covers

A Healthcare Clinical Study Agreement (HCSA) is a written contract between a study sponsor and a research site or investigator that defines responsibilities, deliverables, timelines, budgeting and data handling for a clinical study. Typical HCSA provisions address protocol adherence, subject recruitment and enrollment targets, payment and milestone schedules, intellectual property and publication rights, indemnification and insurance, regulatory compliance including IRB oversight and informed consent, and protections for patient data under HIPAA. The HCSA establishes the legal and operational framework to run the study and allocate risk between parties.

Why a Clear HCSA Matters for Clinical Research

A well-drafted HCSA reduces ambiguity about obligations, payment, data access, and regulatory compliance, lowering the chance of disputes and study delays.

Who Commonly Prepares and Signs an HCSA

Typical parties and stakeholders involved in preparing, negotiating, and executing the HCSA include organizational and operational roles at both sponsor and site.

Study sponsor teams and clinical operations managers responsible for contract terms and funding distribution to sites.
Principal investigators and site administrators who confirm feasibility, staffing, and local regulatory approvals.
Contract research organizations (CROs), legal counsel, and institutional offices of sponsored programs coordinating execution and compliance.

Each stakeholder has distinct priorities — legal and regulatory review, budget reconciliation, operational readiness, and data protections — which should be coordinated before signature.

Core Elements to Include in a Professional HCSA

A complete HCSA addresses operational, financial, regulatory, and legal elements so parties can implement the protocol consistently and document responsibilities.

Scope of Work

Defines trial activities, sites, procedures, enrollment targets, and protocol version control so responsibilities are unambiguous.

Budget & Payments

Details payment milestones, invoicing cadence, allowable costs, expense documentation, and reimbursement procedures for the site.

Regulatory Compliance

Specifies IRB/ethics approvals, reporting obligations, safety reporting timelines, and adherence to applicable federal rules.

Data and PHI

Describes data access, storage, ownership, deidentification, and HIPAA protections including any required authorization language.

IP & Publications

Allocates intellectual property rights, data use for secondary research, and publication review/embargo processes.

Liability & Insurance

Sets indemnity, insurance minimums, limitation of liability, and procedures for breach remediation and dispute resolution.

Step-by-Step: From Draft to Execution

Follow a predictable sequence to reduce rework: gather documents, align stakeholders, confirm compliance, and execute with reliable records.

01

Assemble Documents: Gather protocol, budget template, IRB application, and prior contracts.
02

Negotiate Terms: Resolve payment, IP, publication, and indemnity clauses with legal input.
03

Obtain Approvals: Secure IRB, institutional sign-off, and any sponsor internal approvals.
04

Execute and Archive: Sign contract, capture audit trail, and store final executed copy.

Configuring an Electronic Workflow for HCSA Execution

Design the e-sign workflow to mirror required approval order and evidence capture for audits.

Field	Configuration
Authentication	Email link + SMS code or institutional SSO for higher assurance
Routing Order	Sponsor → Legal → PI → Institutional Official
Attachments	Include protocol, IRB approval letters, budget worksheets
Audit Trail	Keep timestamps, IP addresses, and signer attribution for compliance

Typical eSubmission Flow for a Clinical Study Agreement

An orderly digital flow shortens turnaround while preserving record integrity for audits and inspections.

Upload Document: Upload the HCSA PDF or DOCX to the signing platform.
Place Fields: Add signature, initials, date, and conditional fields as required.
Add Signers: Enter signer emails and assign signing order or parallel signing.
Execute: Signers authenticate and sign; platform captures the certificate of completion.

Technical Requirements for Secure Electronic Signing

Ensure the chosen solution can produce tamper-evident signed records and meet your institution’s compliance checklist.

File Formats: PDF, DOCX and convertible formats supported
Integrations: Connectors for EHRs, NetSuite, Salesforce, and cloud storage
Signer Authentication: Email, SMS code, SSO, or advanced options

Security and Compliance Considerations

Encryption: TLS 1.2/1.3 in transit; AES-256 at rest

HIPAA Support: Business Associate Agreement available when required

Audit Trail: Complete timestamped signature history

Regulatory Standards: 21 CFR Part 11 compliance options

Certifications: SOC 2 Type II and ISO 27001

Accessibility: WCAG 2.0 Level AA conformance

Common Risks and Consequences of a Faulty HCSA

HIPAA Violation: Regulatory fines and corrective action

Invalid Consent: Study data unusable, enrollment halted

Payment Delays: Site cashflow problems and disputes

Regulatory Audit: Inspection findings and remediation costs

Indemnity Exposure: Sponsor or site may face litigation costs

Data Loss: Reputational harm and research setbacks

eSignature Pricing and Feature Snapshot for Clinical Agreements

Comparison of common vendor starting prices and select features relevant to healthcare contracting. Confirm vendor plans for enterprise or add-on functionality.

	signNow	DocuSign	Adobe Sign	PandaDoc	HelloSign
Starting Price	$8/user/mo	$15/user/mo	$14/user/mo	$19/user/mo	$15/user/mo
Free Trial	Yes, 7-day trial	Varies by plan	Varies by plan	Varies by plan	Varies by plan
Bulk Send	Yes (plan dependent)	Yes	Yes	Yes	Varies
Audit Trail	Yes	Yes	Yes	Yes	Yes
HIPAA Compliant	Yes	Yes	Yes	No	No
Envelope Cap	No cap	100 envelopes/user/year	Varies by plan	Varies by plan	Varies by plan

Real-World Example: How Organizations Use Electronic Agreements

These brief examples illustrate practical outcomes when executing clinical or healthcare-related agreements with secure e-signature and workflow controls.

Fertility Centers of Illinois

A midsize clinical practice digitized contract flow to reduce turnaround time by centralizing approvals.

Executive review streamlined internal signatures.
The organization retained a complete audit trail and used a BAA to maintain HIPAA compliance while reducing paper handling and follow-up cycles.

Optica Ventures LLC

A sponsor standardized HCSA templates across studies to speed site onboarding.

Templates reduced negotiation on common clauses.
Centralized templates and consistent payment schedules improved predictability, lowered legal review time, and supported faster site activation.

Typical Timelines and Deadlines for Clinical Study Setup

Timelines vary by study complexity, site capacity, and institutional review board schedules; plan conservatively and track key milestones.

Contract Negotiation:

Often 2–8 weeks depending on complexity and redlines

IRB Review:

Commonly 4–8 weeks; can be shorter with expedited review

Site Activation:

After approvals, typically 1–4 weeks to activate site

Enrollment Window:

Defined in protocol; varies by study and site capacity

Safety Reporting:

Follow protocol timelines and regulatory reporting obligations

Practical Tips for Accurate, Efficient HCSA Completion

Adopt consistent templates, centralize communication, and preserve a complete execution record to reduce downstream friction.

Use Standardized Templates

Reduce negotiation time by predefining commonly accepted clauses and allowable redline areas.

Document Assumptions

Record any oral agreements or conditional approvals within the contract to prevent misinterpretation.

Keep an Audit Trail

Retain timestamps, signer information, and version history for inspections and dispute resolution.

Coordinate Early with IRB

Align contract terms with IRB requirements to avoid rework after ethical review.

Frequently Asked Questions About HCSAs and eSignatures

Answers to common questions about execution, validity, PHI handling, and platform considerations for Healthcare Clinical Study Agreements.

Need help? Contact support

Can an HCSA be signed electronically?
Yes. Electronic signatures are legally enforceable under the federal ESIGN Act (15 U.S.C. ch. 96) and state UETA laws in most jurisdictions, subject to limited statutory exceptions. Confirm institutional policies and any required consent disclosures for consumer-facing or government-funded transactions.
Do I need a HIPAA BAA for eSigning?
If the platform will store or transmit protected health information, a Business Associate Agreement is required to allocate responsibilities and ensure HIPAA safeguards are in place. Verify the platform’s HIPAA compliance options before sending PHI-containing documents.
What signer authentication is sufficient?
Select authentication appropriate to risk: simple email link for low-risk approvals, SMS or SSO for moderate assurance, and multi-factor or institutional SSO for high-assurance clinical agreements involving PHI or substantial payments.
Are notarization or witnesses required?
Not usually for HCSAs, but some institutions or state rules may require notarization for specific signature authorities or amendments. Check institutional policies and state notary guidance before execution.
How do I protect PHI in shared signed documents?
Limit access, redact nonessential identifiers where possible, store executed agreements in secure repositories, and maintain a logging and retention policy consistent with HIPAA and institutional rules.
What records should be retained after study close?
Retain the executed HCSA, protocol versions, IRB approvals, consent forms, and financial records per retention policy; federal and HIPAA baselines apply, and some studies may require longer retention for sponsor or regulator reasons.

be ready to get more

Join over 28 million airSlate SignNow users

Sign Now